Belite Bio, Inc, ADR (BLTE) PT Lowered to $215 at Mizuho

May 26, 2026 5:50 AM

Mizuho analyst Graig Suvannavejh lowered the price target on Belite Bio, Inc, ADR (NASDAQ: BLTE) to $215.00 (from $223.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found